These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36560848)
41. Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma. Chen Z; Zhang W; Yan Z; Zhang M Cancer Med; 2023 Jan; 12(1):760-788. PubMed ID: 35668574 [TBL] [Abstract][Full Text] [Related]
42. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. Yang Q; Gong H; Liu J; Ye M; Zou W; Li H Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696 [TBL] [Abstract][Full Text] [Related]
43. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
44. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas. Li J; Zhang Y; Qu Z; Ding R; Yin X Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373 [TBL] [Abstract][Full Text] [Related]
45. Development and validation of a leukocyte-associated immunoglobulin-like receptor-1 prognostic signature for lower-grade gliomas. Fang Z; Lin L; Tu Z; Zhu X; Li J; Luo P; Huang K; Wu L Cancer Med; 2023 Jan; 12(1):712-732. PubMed ID: 35702880 [TBL] [Abstract][Full Text] [Related]
46. A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment. Li H; Wang G; Wang W; Pan J; Zhou H; Han X; Su L; Ma Z; Hou L; Xue X Front Oncol; 2021; 11():698278. PubMed ID: 34631528 [TBL] [Abstract][Full Text] [Related]
47. Autophagy related DNA methylation signature predict clinical prognosis and immune microenvironment in low-grade glioma. Qiao Q; Wang Y; Zhang R; Pang Q Transl Cancer Res; 2022 Jul; 11(7):2157-2174. PubMed ID: 35966301 [TBL] [Abstract][Full Text] [Related]
48. Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response. Wu Y; Mao M; Wang LJ Aging (Albany NY); 2023 Sep; 15(17):9086-9104. PubMed ID: 37698534 [TBL] [Abstract][Full Text] [Related]
49. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients. Huang S; Zhang J; Lai X; Zhuang L; Wu J Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851 [No Abstract] [Full Text] [Related]
50. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer. Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648 [TBL] [Abstract][Full Text] [Related]
51. Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer. Chen W; Huang J; Xiong J; Fu P; Chen C; Liu Y; Li Z; Jie Z; Cao Y Oxid Med Cell Longev; 2021; 2021():6290261. PubMed ID: 34497681 [TBL] [Abstract][Full Text] [Related]
52. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma. Zhang M; Wang X; Chen X; Zhang Q; Hong J Front Genet; 2020; 11():363. PubMed ID: 32351547 [TBL] [Abstract][Full Text] [Related]
53. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma. Xu S; Tang L; Liu Z; Luo C; Cheng Q Front Immunol; 2021; 12():731048. PubMed ID: 34659218 [TBL] [Abstract][Full Text] [Related]
54. Development of a copper metabolism-related gene signature in lung adenocarcinoma. Chang W; Li H; Zhong L; Zhu T; Chang Z; Ou W; Wang S Front Immunol; 2022; 13():1040668. PubMed ID: 36524120 [TBL] [Abstract][Full Text] [Related]
55. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients. Hu Y; Tu Z; Lei K; Huang K; Zhu X Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238 [TBL] [Abstract][Full Text] [Related]
56. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. Zhou Y; Li X; Long G; Tao Y; Zhou L; Tang J Front Immunol; 2022; 13():994259. PubMed ID: 36341373 [TBL] [Abstract][Full Text] [Related]
57. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma. Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739 [TBL] [Abstract][Full Text] [Related]
58. Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients. Yan Z; Gao Y; Yu J; Shen Z; Bu X J Immunol Res; 2022; 2022():8972730. PubMed ID: 35647198 [TBL] [Abstract][Full Text] [Related]
59. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma. Zhang W; Li L; Bian PP; Luo QP; Xiong ZT Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030 [TBL] [Abstract][Full Text] [Related]
60. A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma. Xia P; Huang Y; Chen G Front Oncol; 2022; 12():940220. PubMed ID: 36033510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]